Segment and Geographic Information (Tables)

9 Months Ended

Jan. 24, 2020

The following tables present reconciliations of financial information from the segments to the applicable line items in the Company's consolidated financial statements:

Net Sales


	Three months ended⁽¹⁾						Nine months ended⁽¹⁾
(in millions)	January 24, 2020		January 25, 2019		January 24, 2020		January 25, 2019
Cardiac and Vascular Group	$	2,819	$	2,786	$	8,464	$	8,455
Minimally Invasive Therapies Group	2,176		2,124		6,418		6,223
Restorative Therapies Group	2,111		2,026		6,235		5,968
Diabetes Group	610		610		1,798		1,765
Total	$	7,717	$	7,546	$	22,916	$	22,411

(1) The data in this schedule has been intentionally rounded to the nearest million and, therefore, may not sum.

Income From Operations Before Income Taxes by Reportable Segment and Reconciliation to Consolidated

Segment Operating Profit


	Three months ended						Nine months ended
(in millions)	January 24, 2020		January 25, 2019		January 24, 2020		January 25, 2019
Cardiac and Vascular Group	$	1,101	$	1,076	$	3,284	$	3,262
Minimally Invasive Therapies Group	860		828		2,453		2,396
Restorative Therapies Group	898		824		2,531		2,394
Diabetes Group	158		190		456		538
Segment operating profit	3,017		2,918		8,724		8,590
Interest expense	(156)		(243)		(930)		(726)
Other non-operating income, net	96		71		305		309
Amortization of intangible assets	(436)		(436)		(1,317)		(1,327)
Corporate	(348)		(331)		(1,005)		(974)
Centralized distribution costs	(348)		(383)		(1,117)		(1,313)
Restructuring and associated costs	(97)		(66)		(315)		(256)
Acquisition-related items	(28)		(17)		(74)		(57)
Certain litigation charges	(108)		(63)		(276)		(166)
IPR&D charges	—		(11)		—		(26)
Exit of businesses	—		(69)		(41)		(149)
Debt tender premium and other charges	—		—		7		—
Medical device regulations	(13)		—		(31)		—
Contribution to Medtronic Foundation	—		—		(80)		—

Income before income taxes	$	1,579	$	1,370	$	3,850	$	3,905

Net Sales to External Customers by Geography

The following table presents net sales for the three and nine months ended January 24, 2020 and January 25, 2019 for the Company's country of domicile, countries with significant concentrations, and all other countries:


	Three months ended						Nine months ended
(in millions)	January 24, 2020		January 25, 2019		January 24, 2020		January 25, 2019
Ireland	$	22	$	24	$	66	$	68

United States	4,021		4,001		12,068		11,910
Rest of world	3,674		3,521		10,782		10,433
Total other countries, excluding Ireland	7,695		7,522		22,850		22,343
Total	$	7,717	$	7,546	$	22,916	$	22,411